Evidence-audited guides decoding FDA food-effect bioavailability studies ("Take With Food"), FDA Orange Book 80%–125% generic bioequivalence (3.5% mean AUC difference across 2,070 human studies), and AHRQ 15-minute doctor visit question checklists. Explore 188 indexed studies and multi-trial syntheses with verified PubMed PMIDs, participant sample sizes (N), and Absolute vs. Relative Risk numbers.
The Plain-English Receipt: Only 1.2% of prediabetic adults on Tirzepatide progressed to Type 2 diabetes over 3.4 years vs. 19.3% on placebo (Absolute Risk Reduction = 18.1% • Number Needed to Treat = 6).
After 8 weeks of treatment, the results of nocturnal penile tumescence studies evaluating rigidity and circumference were significantly different from those in the placebo group (P < 0.05) and comparable to those during T...
The AUC and cumulative release of testosterone were linearly related to the number of applied systems.
Single injections of 600 mg TB in hypogonadal patients show favorable how the body absorbs the medicine and how the medicine works in the body.
It is concluded that, compared with an equivalent dose of PE1S, daily repeated oral administration of E2V yields consistently lower peripheral plasma levels of E2 and its principal metabolites.
Nanodispersible CBD was therapeutically safe with no serious side effects, well tolerated, and effective for the treatment of mild to moderate anxiety, as well as associated depression and sleep quality disturbances.
CAS+IMD treatment of pregnant outpatients with COVID-19 showed similar safety, clinical outcomes and how the body absorbs the medicine profiles to that observed in non-pregnant adults.
For gastrointestinal TEAEs, the incidence was related to infection type with higher incidence in Schistosoma mansoni-infected children.
There were no differences in patients' perceptions of bupropion products.
MRHC showed comparable bioavailability to IRHC based on cortisol AUC after 20 mg administration.
This study demonstrated that a newly developed FDCP containing amlodipine, losartan, ezetimibe, and rosuvastatin exhibited how the body absorbs the medicine equivalence with the individual products and met the regulatory criteria.
There was a slight increase in patients achieving sustained full symptom relief at Week 52 and a decrease in absolute neutrophil count with increasing sarilumab C trough plateauing at 20-25 mg/L.
Greater staying on track with medication to app-based dose guidance was associated with greater estimated improvements in pre-breakfast SMBG and higher weekly insulin dose.
The results of this subgroup analysis of PUNCH CD3-OLS suggest RBL is safe and efficacious in patients with IBD.
Eighty healthy Chinese volunteers (89.9% male; mean age, 28.7 years) were randomized into cohort 1 (n = 40) and cohort 2 (n = 39; 1 volunteer withdrew before receiving study treatment).
The results of this study strongly suggest that concomitant treatment with nisoldipine enhances telmisartan bioavailability in hypertensive individuals.
Both sildenafil citrate formulations were generally well tolerated in healthy Chinese men.
Vilobelimab therapy provides a cost-effective option to treat severely ill, mechanically ventilated patients with COVID-19 with.
Oral testosterone administration resulted in a therapeutic serum testosterone concentration in hypogonadal men.
Rosuvastatin exposure was moderately higher with filgotinib getting both at the same time-GLSM ratios (90% CI), 1.68 (1.43-1.97) for C max ; 1.42 (1.30-1.57) for AUC inf -but this was not considered clinically relevant.
The getting both at the same time of rosuvastatin and ezetimibe revealed a bioequivalent PK interaction.
Combined administration of rosuvastatin and ezetimibe was well tolerated.
Most side effects were mild in nature.
Psychosis relapse risk was significantly lower with pimavanserin vs.
In contrast nadir FSH levels occurred at similar times but remained elevated compared with eugonadal controls.
Both reached C(max) ~1.5 hours later with liraglutide.
Compared with insulin, liraglutide decreased CNS activation significantly only after short-term treatment, suggesting that these effects of GLP-1RA on the CNS may contribute to the induction of weight loss, but not necessarily...
The marketed 150-mg tablet formulation of peficitinib was bioequivalent to the developmental 150-mg formulation, with no discernible safety differences.
Simulated furosemide exposure was consistent with published values, supporting an 80-mg dose of subcutaneous furosemide (30 mg over the first hour, then 12.5 mg/h for 4 h) for adolescents aged 12-17 years with body weight ≥...
The results suggest that there would be no significant changes in the how the body absorbs the medicine of estradiol between women under 60 and over 65 years of age.
Among rosuvastatin patients (n = 156), there was no difference in dose needed to reach target LDL-C, measured LDL-C, or lathosterol concentrations, when administered in a fed or fasting state.
Traditional health headlines often exaggerate findings by reporting only Relative Risk Reduction—for example, claiming a drug cuts risk by 50% when the event rate dropped from 2% to 1% (an Absolute Risk Reduction of just 1.0 percentage point, meaning 100 patients must take the drug for 1 person to benefit, or NNT = 100). On dotMD, every flagship study breakdown reports both Relative Risk and Absolute Risk alongside the exact sample size (N) and trial duration.
Every study on dotMD displays its exact Study Design Tier at the top of the card (Phase 3 Randomized Trial, Randomized Controlled Trial, Meta-Analysis & Systematic Review, Multi-Trial Clinical Evidence Synthesis, Journal Watch Cohort, or FDA Safety Alert) along with the human participant count (N). Preclinical mouse or cell-culture data is never presented as human clinical proof.
Arbitrary 0-to-100 rigor scores obscure what actually makes a study trustworthy. Instead of synthetic scores, dotMD surfaces the verifiable primary evidence signals: exact NCBI PubMed IDs (PMID), ClinicalTrials.gov registration numbers (NCT), double-blind vs. crossover design, sample size (N), p-values / Hazard Ratios, and study limitations.
Medical research is only useful if you can act on it safely with your clinician. Every flagship research synthesis links directly to the parent Condition diagnostic cutoff guide, the Medication FDA DailyMed & CMS NADAC wholesale price ledger, the Supplement elemental weight decoder, and our High-CPT-Volume Specialist Directory.
